Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » 2017

2017

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 10/07/19 by Kate Wood

Proposal for the reduction in observation time post administration of subcutaneous Herceptin

Abstracts

View resources
Last reviewed: 10/07/19 by Ben Eliott

Exploring the assessment skills required by pharmacist independent prescribers for the safe prescribing of systemic anti-cancer therapy 

Abstracts

View resources
Last reviewed: 17/03/21 by David Breen

Pharmacist Led Myelopfoliferative Neoplasm Clinic An Audit of Current Practice

Abstracts

View resources
Last reviewed: 10/07/19 by Darren Walsh

Audit of Oral Anticancer Medication Prescribing in University Hospital Waterford

Abstracts

View resources
Last reviewed: 17/03/21 by Nicola Stoner

The Administration of Immunooncology Agents in UK Clinical Practice

Abstracts

View resources
Last reviewed: 10/07/19 by Calum Polwart

Using Meta-analysis to develop an Audit Standard for the Rapid Infusion of Bio-similar Rituximab

Abstracts

View resources
Last reviewed: 10/07/19 by B. Buijtenhuijs

Is the use of GCSF justified in patients receiving Docetaxel for castrate resistant prostate cancer?

Abstracts

View resources
Last reviewed: 10/07/19 by Louisa Davies

DPD deficiency testing – An Overview of Current Variations in Practice

Abstracts

View resources
Last reviewed: 17/03/21 by Bansi Shah

A retrospective audit to assess if outpatient prescribing of oral antiemetic(s) complies with antiemetic guidelines for adult patients receiving chemotherapy and/or radiotherapy at the Macmillan Dispensary

Abstracts

View resources
Last reviewed: 17/03/21 by Philip Murphy

Impact of education programme on biosimilar attitudes and beliefs

Abstracts

View resources
Last reviewed: 10/07/19 by Christopher Watson

Development of a Parenteral Systemic Anticancer Therapy (SACT) Dispensing Service Funded by Savings Generated from Implementation of National Dose Banding Tables and Switching to Readymade Doses

Abstracts

View resources
Last reviewed: 10/07/19 by Mark Evans

A Survey of the oncology pharmacy workforce and assessment of capability to undertake advanced roles in the cancer setting.

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 2 3 4 … 8 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.